Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences (BMLS), Goethe University Frankfurt am Main, Max-von-Laue-Str. 15, Frankfurt am Main 60438, Germany.
Institut für Pharmazeutische Chemie, Goethe University Frankfurt am Main, Max-von-Laue-Str. 9, Frankfurt am Main 60438, Germany.
J Med Chem. 2021 Oct 14;64(19):14358-14376. doi: 10.1021/acs.jmedchem.1c00845. Epub 2021 Sep 20.
CASK (Ca/calmodulin-dependent Ser/Thr kinase) is a member of the MAGUK (membrane-associated guanylate kinase) family that functions as neurexin kinases with roles implicated in neuronal synapses and trafficking. The lack of a canonical DFG motif, which is altered to GFG in CASK, led to the classification as a pseudokinase. However, functional studies revealed that CASK can still phosphorylate substrates in the absence of divalent metals. CASK dysfunction has been linked to many diseases, including colorectal cancer, Parkinson's disease, and X-linked mental retardation, suggesting CASK as a potential drug target. Here, we exploited structure-based design for the development of highly potent and selective CASK inhibitors based on 2,4-diaminopyrimidine-5-carboxamides targeting an unusual pocket created by the GFG motif. The presented inhibitor design offers a more general strategy for the development of pseudokinase ligands that harbor unusual sequence motifs. It also provides a first chemical probe for studying the biological roles of CASK.
CASK(钙/钙调蛋白依赖性丝氨酸/苏氨酸激酶)是 MAGUK(膜相关鸟苷酸激酶)家族的成员,作为神经连接素激酶发挥作用,其功能涉及神经元突触和运输。由于缺乏典型的 DFG 基序(在 CASK 中被改变为 GFG),CASK 被归类为假激酶。然而,功能研究表明,CASK 可以在没有二价金属的情况下仍然磷酸化底物。CASK 功能障碍与许多疾病有关,包括结直肠癌、帕金森病和 X 连锁智力迟钝,这表明 CASK 是一个潜在的药物靶点。在这里,我们利用基于结构的设计,针对由 GFG 基序形成的不寻常口袋,开发了基于 2,4-二氨基嘧啶-5-甲酰胺的高度有效和选择性的 CASK 抑制剂。所提出的抑制剂设计为假激酶配体的开发提供了一种更通用的策略,这些配体具有不寻常的序列基序。它还提供了第一个用于研究 CASK 生物学作用的化学探针。